Literature DB >> 7697342

Tumor suppression. Lessons in p16 from phylum Falconium.

R J Sheaff1, J M Roberts.   

Abstract

Increasingly, biochemical and genetic evidence indicates that mutations in the gene encoding p16, an inhibitor of cyclin-dependent kinases, may play a role in some forms of hereditary and sporadic tumors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697342     DOI: 10.1016/s0960-9822(95)00009-1

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  8 in total

1.  Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins.

Authors:  J Hermanns; A Schulze; P Jansen-Db1urr; J A Kleinschmidt; R Schmidt; H zur Hausen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence.

Authors:  E Hara; R Smith; D Parry; H Tahara; S Stone; G Peters
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

3.  Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma.

Authors:  D Parry; G Peters
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  Growth suppression by p16ink4 requires functional retinoblastoma protein.

Authors:  R H Medema; R E Herrera; F Lam; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

5.  HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.

Authors:  T Suzuki; S Kitao; H Matsushime; M Yoshida
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

6.  Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours.

Authors:  S Marchini; A M Codegoni; C Bonazzi; S Chiari; M Broggini
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Newt myotubes reenter the cell cycle by phosphorylation of the retinoblastoma protein.

Authors:  E M Tanaka; A A Gann; P B Gates; J P Brockes
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

8.  Inhibition of cyclin D1 expression and induction of apoptosis by inostamycin in small cell lung carcinoma cells.

Authors:  M Imoto; K Tanabe; S Simizu; E Tashiro; M Takada; K Umezawa
Journal:  Jpn J Cancer Res       Date:  1998-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.